【摘要】 运用5312例孕妇的筛查和28例先心病患儿诊断和治疗的数据,分析先天性心脏病产前诊断和干预的成本效益。对实际发生的筛查和干预、治疗成本进行成本测算,估算干预成本效益。结果表明先心病筛查干预措施的效益成本比率为15:1;证实先心病产前诊断对先心病的干预具有重要意义。更多还原

【Abstract】 Cost-benefit analysis was applied to evaluate the congenital heart disease screening and prevention method. The related data of 5312 pregnant women and 28 congenital heart disease cases was collected during the study period. The actual cost of the screening, prevention and treatment was measured, while the benefit of the prevention was evaluated. The result indicated that the ratio of cost for pre-maternity diagnosis benefit is 15 times. It proved strongly that per-maternity diagnosis played an important role in the prevention of congenital heart disease.更多还原